>>8999379

>>8999418

from Sabo

>>8999345

Gilead Sciences Licenses Portfolio of HIV Antibodies From The Rockefeller University

January 09, 2020

FOSTER CITY, Calif.(BUSINESS WIRE)Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the company has licensed The Rockefeller University’s portfolio of broadly neutralizing antibodies (bNAbs) against HIV, including the two clinical-stage agents 3BNC117 and 10-1074.

These investigational agents have potential for use in HIV long-acting therapies for treatment and prevention, as well as cure strategies.

https://www.businesswire.com/news/home/20200109005277/en/Gilead-Sciences-Licenses-Portfolio-HIV-Antibodies-Rockefeller

>>8999647

"A story should have a beginning, a middle and an end, but not necessarily in that order."

• Jean-Luc Godard